| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |